We are live on ! Find out more
PAHC icon

Phibro Animal Health

133 hedge funds and large institutions have $311M invested in Phibro Animal Health in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 53 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more call options, than puts

Call options by funds: $141K | Put options by funds: $60K

21% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 14

19% more capital invested

Capital invested by funds: $261M → $311M (+$49.9M)

4.08% more ownership

Funds ownership: 95.73%99.81% (+4.1%)

2% more funds holding

Funds holding: 131133 (+2)

17% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 53

Holders
133
Holders Change
+2
Holders Change %
+1.53%
% of All Funds
2.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
44
Reduced
53
Closed
14
Calls
$141K
Puts
$60K
Net Calls
+$81K
Net Calls Change
+$52K

PAHC Hedge Fund Activity: Q1 2023 in Review

133 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2023, worth a combined $311M — up 19% from $261M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PAHC positions and 14 closed out — a net gain of 3 holders — while 44 added to existing stakes and 53 trimmed.

The largest buyer was Brandes Investment Partners, adding an estimated $9.79M. The largest seller was BlackRock, cutting an estimated $3.21M.

  • 133 institutional investors held Phibro Animal Health (PAHC) as of Q1 2023, up from 131 in Q4 2022.
  • Funds reported $311M of Phibro Animal Health stock for Q1 2023, up 19% quarter-over-quarter.
  • 17 funds opened new Phibro Animal Health positions in Q1 2023 and 14 closed out, a net change of +3 holders.
  • The largest Phibro Animal Health buyer in Q1 2023 was Brandes Investment Partners, an estimated $9.79M added.
  • The largest Phibro Animal Health seller in Q1 2023 was BlackRock, an estimated $3.21M sold.

Based on aggregated 13F filings for Q1 2023.